Global liquid biopsy market is projected to witness a steady growth during the forecasted period 2018-2023. The rising prevalence of cancer diseases, high investment in R&D and growing preference for minimally invasive technology over alternate invasive methods are the driving factors of the liquid biopsy market. however, lack of awareness in developing and underdeveloped countries hamper the growth of the market. Moreover, technological advancement in a liquid biopsy with growing investment and funding for R&D create a future opportunity for the growth of the market during the forecast period.
Request a free sample of our report on Liquid Biopsy Market: https://www.omrglobal.com/request-sample/liquid-biopsy-market
Global liquid biopsy market is segmented on the basis of biomarker type, cancer type, and end-user. According to the biomarker type, the market is further sub-segmented as circulating tumor cells, circulating tumor DNA and others such as extracellular vesicles. According to the cancer type, the market is further diversified as lung cancer, breast cancer, prostate cancer, colorectal cancer, and others. Moreover, according to the end-user, the market is further diversified as hospitals and laboratories, and academic and research institutes.
Global liquid biopsy market can be geographically segmented into North America, Europe, Asia-Pacific and Rest of the World. High prevalence of cancer diseases and the investment in R&D in the US has boosted the growth of the market in North America. The rapidly developing economies of Asia-Pacific are projected to witness the highest growth rate during the forecasted period. The growth in the Asia-Pacific market is backed by the growing awareness about the diagnosis and treatment for cancer diseases within the countries. Along with it, efforts by the government funding on research programs is aiding in the growth of the Asia-Pacific liquid biopsy market.
A full report of Liquid Biopsy Market is available at: https://www.omrglobal.com/industry-reports/liquid-biopsy-market
Global Liquid Biopsy Market Segmentation
By Biomarker Type
Circulating Tumor Cells
Circulating Tumor DNA (ctDNA)
Others (Extracellular Vesicles)
By Cancer Type
Hospitals and Laboratories
Academic and Research Centres
Key Company Analysis
Key Strategy Analysis
Rest of Asia-Pacific
Rest of The World
Bio-Rad Laboratories Inc.
Clearbridge Biomedics Pte Ltd.
Cynvenio Biosystems, Inc.
Exosome Diagnostics Inc.
F. Hoffmann-La Roche AG
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/liquid-biopsy-market
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit https://www.omrglobal.com/
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404